semaglutide patent india Expiration in India: SNAC Manufacturer | Ronak Mehta posted on the topic Novo Launches Ozempic in India

Each has different FDA approvals, insurance coverage patterns, and effectiveness profiles

The varying regulatory standards across different countries can complicate global marketing strategies, as companies must navigate different approval processes and compliance requirements, making market entry challenging

But the wheels of the insurance industry turn excruciatingly slowly

Responding to complaints about high costs, Eli Lilly, maker of Zepbound, says in part: "Obesity is a chronic, progressive disease, and people with obesity deserve for it to be treated like one." Doctors say insurance will still cover the drugs for things like diabetes